Insider · CIK 0002013388
Daniel LeSueur
Files at HCAT (Health Catalyst, Inc.). First filing Nov 7, 2024, latest May 7, 2025.
Daniel LeSueur files SEC Form 4 as COO at HCAT (Health Catalyst, Inc.). Since Nov 7, 2024, Daniel LeSueur has reported 0 open-market buys worth $0 and 7 open-market sells worth $404k, the latest filed on May 7, 2025.
A track record needs three past buys with six months of prices behind them; Daniel LeSueur has 0, so none is measured yet.
The newest scored trade: sold $21k of HCAT on May 5, 2025, filed May 7, 2025, scored 0 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HCAT: Health Catalyst, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Health Catalyst, Inc. | $21k 5,209 shares | -2% | +14% from low-55% from high | |
| 0Weak | Health Catalyst, Inc. | $22k 5,209 shares | -2% | +4% from low-54% from high | |
| 16Weak | Health Catalyst, Inc. | $76k 16,902 shares | -7% | +4% from low-50% from high | |
| 13Weak | Health Catalyst, Inc. | $30k 5,209 shares | -6% | +8% from low-35% from high | |
| 21Weak | Health Catalyst, Inc. | $39k 5,209 shares | -5% | +7% from low-18% from high | |
| 32Weak | Health Catalyst, Inc. | $175k 22,773 shares | -19% | - | |
| 14Weak | Health Catalyst, Inc. | $40k 5,209 shares | -4% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 2, 2025 | HCAT Health Catalyst, Inc | 3,663 0.01% of outstanding | $12k | Sep 2, 2025 | $14k |
| Jun 2, 2025 | HCAT Health Catalyst, Inc. | 3,802 0.01% of outstanding | $14k | Jun 2, 2025 | $162k |
| Apr 3, 2025 | HCAT HEALTH CATALYST INC | 10,418 0.01% of outstanding | $46k | Apr 3, 2025 | $188k |
| Mar 5, 2025 | HCAT HEALTH CATALYST INC | 16,902 0.02% of outstanding | $76k | Mar 5, 2025 | $111k |
| Mar 3, 2025 | HCAT Health Catalyst, Inc. | 9,232 0.01% of outstanding | $42k | Mar 3, 2025 | $338k |
| Feb 5, 2025 | HCAT HEALTH CATALYST INC | 5,209 0.01% of outstanding | $29k | Feb 5, 2025 | $308k |
| Jan 6, 2025 | HCAT HEALTH CATALYST, INC. | 5,209 0.01% of outstanding | $39k | Jan 6, 2025 | $309k |
| Dec 4, 2024 | HCAT HEALTH CATALYST INC | 22,773 0.04% of outstanding | $181k | Dec 4, 2024 | $174k |
| Dec 2, 2024 | HCAT Health Catalyst, Inc. | 10,455 0.02% of outstanding | $94k | Dec 2, 2024 | $155k |
| Nov 5, 2024 | HCAT HEALTH CATALYST INC | 5,209 0.01% of outstanding | $40k | Nov 5, 2024 | $115k |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -3,663 | $3.36 | $12k | 198,367 | Sep 4, 2025 |
| Jun 2, 2025 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -3,802 | $3.63 | $14k | 202,030 | Jun 3, 2025 |
| May 5, 2025 | HCAT Health Catalyst, Inc. | SOpen-market sale Common Stock10b5-1 | -5,209 | $4.10 | $21k | 205,832 | May 7, 2025 |
| Apr 3, 2025 | HCAT Health Catalyst, Inc. | SOpen-market sale Common Stock10b5-1 | -5,209 | $4.15 | $22k | 211,041 | Apr 7, 2025 |
| Mar 5, 2025 | HCAT Health Catalyst, Inc. | SOpen-market sale Common Stock10b5-1 | -16,902 | $4.52 | $76k | 216,250 | Mar 10, 2025 |
| Mar 3, 2025 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -9,232 | $4.58 | $42k | 233,152 | Mar 4, 2025 |
| Feb 20, 2025 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +145,000 | $0.00 | $0 | 231,044 | Feb 24, 2025 |
| Feb 20, 2025 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +11,340 | $0.00 | $0 | 242,384 | Feb 24, 2025 |
| Feb 5, 2025 | HCAT Health Catalyst, Inc. | SOpen-market sale Common Stock10b5-1 | -5,209 | $5.76 | $30k | 86,044 | Feb 6, 2025 |
| Jan 6, 2025 | HCAT Health Catalyst, Inc. | SOpen-market sale Common Stock10b5-1 | -5,209 | $7.51 | $39k | 91,253 | Jan 10, 2025 |
| Dec 4, 2024 | HCAT Health Catalyst, Inc. | SOpen-market sale Common Stock10b5-1 | -22,773 | $7.70 | $175k | 96,462 | Dec 6, 2024 |
| Dec 1, 2024 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -10,455 | $8.97 | $94k | 119,235 | Dec 3, 2024 |
| Nov 5, 2024 | HCAT Health Catalyst, Inc. | SOpen-market sale Common Stock10b5-1 | -5,209 | $7.70 | $40k | 129,690 | Nov 7, 2024 |
Questions about Daniel LeSueur
Answered from the filings on this page, as of the latest one.
Is Daniel LeSueur buying or selling?
Not in the last 12 months. Daniel LeSueur's latest open-market trade on SEC Form 4 was sold $21k of HCAT on May 5, 2025.
How did Daniel LeSueur's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Daniel LeSueur has 0.
Where does Daniel LeSueur file Form 4?
Daniel LeSueur has filed Form 4 at HCAT (Health Catalyst, Inc.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.